Janney Montgomery Scott LLC Has $4.53 Million Holdings in Exponent, Inc. (NASDAQ:EXPO)

Janney Montgomery Scott LLC cut its stake in shares of Exponent, Inc. (NASDAQ:EXPOFree Report) by 5.7% in the fourth quarter, Holdings Channel reports. The firm owned 50,831 shares of the business services provider’s stock after selling 3,069 shares during the quarter. Janney Montgomery Scott LLC’s holdings in Exponent were worth $4,529,000 at the end of the most recent quarter.

A number of other institutional investors have also made changes to their positions in the stock. Marshall Wace LLP bought a new position in Exponent during the second quarter worth about $1,272,000. Cubist Systematic Strategies LLC bought a new position in Exponent during the second quarter worth about $293,000. AQR Capital Management LLC lifted its holdings in Exponent by 73.6% during the second quarter. AQR Capital Management LLC now owns 68,265 shares of the business services provider’s stock worth $6,493,000 after acquiring an additional 28,940 shares in the last quarter. Algert Global LLC lifted its holdings in Exponent by 23.1% during the second quarter. Algert Global LLC now owns 27,139 shares of the business services provider’s stock worth $2,581,000 after acquiring an additional 5,094 shares in the last quarter. Finally, Creative Planning lifted its holdings in Exponent by 56.5% during the second quarter. Creative Planning now owns 17,070 shares of the business services provider’s stock worth $1,624,000 after acquiring an additional 6,164 shares in the last quarter. 92.37% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, Director Paul R. Johnston sold 14,000 shares of the business’s stock in a transaction dated Wednesday, November 6th. The stock was sold at an average price of $104.60, for a total value of $1,464,400.00. Following the sale, the director now directly owns 80,742 shares in the company, valued at $8,445,613.20. The trade was a 14.78 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Carol Lindstrom sold 1,039 shares of the business’s stock in a transaction dated Monday, November 4th. The shares were sold at an average price of $96.32, for a total value of $100,076.48. Following the completion of the sale, the director now owns 5,871 shares in the company, valued at approximately $565,494.72. This trade represents a 15.04 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 30,339 shares of company stock worth $3,103,065. Corporate insiders own 2.10% of the company’s stock.

Exponent Trading Down 1.3 %

EXPO stock opened at $91.26 on Thursday. The business’s 50-day moving average price is $92.93 and its two-hundred day moving average price is $101.33. The firm has a market cap of $4.63 billion, a PE ratio of 44.09 and a beta of 0.71. Exponent, Inc. has a 1-year low of $68.70 and a 1-year high of $115.75.

Exponent Company Profile

(Free Report)

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.

See Also

Want to see what other hedge funds are holding EXPO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exponent, Inc. (NASDAQ:EXPOFree Report).

Institutional Ownership by Quarter for Exponent (NASDAQ:EXPO)

Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.